Venture_Socks_RZ_RGB_300dpi(2)_edited.pn
icon-prizes.png

WINNERS

orange arrows.png

Polyneuron Pharmaceuticals

2014

Health & Nutrition

2000_W1_Carbofix.png
Sensirion_edited.jpg

Polyneuron develops a new drug class for the treatment of autoimmune diseases affecting the nervous system. Their Antibody-Catch™ platform technology enables the rational design of immunomodulatory compounds that selectively eliminate disease-causing autoantibodies. The platform carries the potential to realize breakthrough therapies for specific autoimmune conditions.